CAMP anticorps
-
- Antigène Voir toutes CAMP (cAMP) Anticorps
- CAMP (cAMP) (Cyclic Adenosine Monophosphate (cAMP))
- Reactivité
- Veuillez nous consulter SVP
-
Hôte
-
Mouton
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CAMP est non-conjugé
-
Application
- Enzyme Immunoassay (EIA)
- Purification
- Ig Fraction
- Immunogène
- Cyclic AMP-BSA
- Isotype
- IgG
- Top Product
- Discover our top product cAMP Anticorps primaire
-
-
- Indications d'application
-
ELISA: 6.05 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 6.05mg/mL (U.V. abs at 280nm)
- Buffer
- 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freezing and thawing.
- Stock
- -20 °C
-
- Antigène
- CAMP (cAMP) (Cyclic Adenosine Monophosphate (cAMP))
- Autre désignation
- cAMP / Cyclic AMP (cAMP Produits)
- Synonymes
- anticorps CRAMP, anticorps CAP-18, anticorps CAP18, anticorps FALL-39, anticorps FALL39, anticorps LL37, anticorps CAP11, anticorps Cnlp, anticorps Cramp, anticorps MCLP, anticorps CATHL7, anticorps cathelicidin antimicrobial peptide, anticorps Camp, anticorps CAMP
- Classe de substances
- Chemical
- Sujet
- Cyclic adenosine monophosphate (cAMP) plays a key role as an intracellular second messenger for transduction events that follow a number of extracellular signals. The G-Protein Coupled Receptors (GPCR) is the largest family of cell surface receptors. They can be activated by different ligands, such as neurotransmitters, hormones, ions, small molecules, peptides, and other physiological signaling molecules. Typically, the binding of the ligands to its receptor resulting in the activation of G-proteins, in return, activates the effector adenylyl cyclase evoking the production of cAMP. The activation of a protein kinase by cAMP results in the phosphorylation of substrate proteins. Currently successful drugs in marketing have been developed to target these receptors. Among the GPCRs, ~367 receptors are potential drug development targets, but only about 20 have been used to generate therapeutically and commercially successful drugs so far. Because the involvement of cAMP can amplify the response of the ligand binding, the second messenger cAMP has been largely employed to monitor the activation of the GPCR to facilitate the therapeutic drug discovery.
- Pathways
- Cellular Response to Molecule of Bacterial Origin
-